# Patent Technical Disclosure: Application Genome Modeling, Extraction, and Portability

## Title

**System and Method for Modeling, Extracting, and Representing Application Genomes as Canonical Intermediate Representations of Application Intent, Structure, and Behavior from Enterprise Software Systems**

---

## 1. Field of Invention

This invention relates to application genome modeling, customer data portability, intellectual property extraction, enterprise application migration, cross-platform interoperability, and vendor lock-in remediation. Specifically, it describes a system and method for:

1. **Defining and producing an application genome** -- a canonical representation of application intent, structure, and behavior that captures the totality of a software application's business logic, behavioral patterns, process intent, UI semantics, system interactions, data models, and operational rules in a platform-neutral, implementation-independent form.

2. **Extracting application genomes** from enterprise software systems -- including but not limited to configuration-driven platforms, low-code/no-code platforms, SaaS applications, and custom-built enterprise systems -- by separating customer-authored business logic independent of platform-specific implementation from the proprietary implementation framework of the originating system.

3. **Maintaining application genomes** as persistent, versioned, reusable systems of record that serve as the authoritative representation of an application's business intent across its lifecycle, independent of any particular deployment platform or technology stack.

The system operates on customer-provided application artifacts and at no point accesses, copies, decompiles, or reverse engineers proprietary platform execution code, platform runtime architecture, or internal vendor APIs and system logic.

---

## 2. Background and Prior Art Gaps

Enterprise customers invest significant intellectual effort in designing business processes, approval workflows, data models, catalog structures, and operational logic. These designs represent the customer's intellectual property -- the customer conceived the business requirements, designed the processes, and specified the rules. When implemented on enterprise software systems -- whether configuration-driven platforms, low-code/no-code environments, SaaS applications, or custom-built enterprise systems -- the customer's IP becomes embedded in system-specific artifacts (configuration exports, metadata packages, API definitions, UI specifications, process definitions, video demonstrations, and documentation), commingled with -- but conceptually distinct from -- the system's proprietary implementation.

Current challenges:

- **Vendor lock-in**: Customer-authored business logic is stored in proprietary formats that can only be interpreted by the originating system, creating dependency on a single vendor or technology stack.
- **IP entanglement**: The customer's intellectual property (business process designs, workflow logic, data models, UI semantics, system interaction patterns) becomes entangled with the system's proprietary implementation framework, making it difficult to determine what belongs to the customer versus the platform.
- **Export limitations**: System export tools produce system-specific artifacts that cannot be used on other platforms without extensive manual translation.
- **Loss of business context**: When customers attempt to migrate, the business intent behind configurations is often lost because it exists only in the system-specific implementation, not in a portable, canonical form.
- **No canonical application model**: No standard representation exists for capturing the complete intent, structure, and behavior of an application independent of its implementation platform.
- **Fragmented application knowledge**: Application knowledge is distributed across multiple artifact types (configurations, APIs, documentation, video walkthroughs, process diagrams) with no unified model to integrate them.
- **Legal ambiguity**: Without a clean separation between customer IP and platform implementation, questions of ownership and portability remain unresolved.

**Gaps in prior art:**

1. No existing system defines an **application genome** as a canonical representation of application intent, structure, and behavior encompassing behavioral patterns, process intent, UI semantics, and system interactions in a platform-neutral form.
2. No existing system **extracts customer-authored business logic independent of platform-specific implementation** from enterprise software systems and produces a canonical intermediate representation suitable for cross-platform portability.
3. No existing system produces a **platform-neutral portable architecture** (domain model, application services, API surface, UI model, automation rules, behavioral patterns, system interaction maps) from system-specific artifacts, excluding proprietary execution code and internal APIs.
4. No existing system employs a **multi-agent AI pipeline** with specialized agents for multi-modal ingestion, extraction, deduplication, deep behavioral analysis, platform transformation, and validation to decompose application genome extraction into coordinated subtasks.
5. No existing system supports **multi-modal extraction** of application genomes from heterogeneous artifact types including configuration exports, API specifications, video demonstrations, business documents, and process diagrams.
6. No existing system **merges artifacts from multiple sources and modalities** into a unified application genome, handling deduplication of entities, normalization of naming, and conflict resolution across artifact types.
7. No existing system extracts **reusable behavioral patterns** (inventory management, approval flows, request lifecycles, status transitions, escalation chains) from application artifacts, abstracting them from system-specific terminology.
8. No existing system provides a **completeness and rebuildability assessment** that quantifies whether the extracted application genome is sufficient to reconstruct the application on another platform.
9. No existing system maintains the application genome as a **persistent, versioned system of record** that evolves with the application across its lifecycle and across platform migrations.
10. No existing system represents the application genome in both **flat (tabular/document) and graph (entity-relationship/dependency) schemas** simultaneously, enabling different consumption patterns for different downstream uses.
11. No existing system employs **deterministic and non-deterministic processing stages** in a coordinated hybrid pipeline for application genome extraction, combining rule-based parsing with AI-driven semantic analysis.
12. No existing system enforces **legal boundary mechanisms** that systematically remove system-specific identifiers, schemas, and execution constructs to prevent reconstruction of proprietary runtime behavior or internal APIs.

---

## 3. Definition of Application Genome

An **application genome** as defined by this invention is a canonical representation of application intent, structure, and behavior. It is the complete, platform-neutral model of what an application does, why it does it, and how users and systems interact with it -- expressed independently of how any particular platform implements it.

The application genome comprises the following facets:

### 3.1 Structural Facet

The structural facet captures the static architecture of the application:

- **Domain Model**: The entities, data objects, and their relationships that form the application's information architecture (e.g., "HR Case has many Tasks; each Task is assigned to an Agent Group")
- **Data Schema**: Field definitions, types, constraints, and validation rules expressed as business-level specifications independent of any database implementation
- **Taxonomy**: Classification hierarchies, categorization systems, and organizational structures authored by the customer

### 3.2 Behavioral Facet

The behavioral facet captures the dynamic logic of the application:

- **Business Rules**: Declarative trigger-condition-action specifications that encode the customer's operational logic (e.g., "when a case is created in the West region, assign to the Western HR team")
- **Behavioral Patterns**: Reusable, named abstractions of common business behaviors (e.g., "approval-chain," "inventory-decrement," "SLA-escalation") expressed in domain language
- **State Machines**: Status transitions and lifecycle progressions that govern how business entities evolve over time
- **Event Mappings**: Trigger-effect relationships that capture the customer's event-driven business logic

### 3.3 Process Intent Facet

The process intent facet captures the orchestrated sequences of business operations:

- **Workflows**: Ordered sequences of business steps with actors, actions, decision points, and outcomes
- **Process Flows**: End-to-end business processes that span multiple entities and actors
- **Approval Chains**: Multi-level authorization and delegation patterns
- **Escalation Paths**: Exception-handling and escalation sequences triggered by business conditions

### 3.4 UI Semantics Facet

The UI semantics facet captures the user experience intent without encoding visual implementation:

- **Screen Specifications**: Abstract descriptions of user-facing screens with purpose, audience, and functional components
- **Form Definitions**: Input collection specifications with field types, validation, conditional visibility, and submission behavior
- **Navigation Structure**: Application navigation topology and access patterns
- **Component Semantics**: The business purpose and behavior of UI elements independent of rendering technology (e.g., "employee lookup field" rather than "typeahead widget with REST datasource")

### 3.5 System Interaction Facet

The system interaction facet captures how the application connects to and communicates with external systems:

- **Integration Points**: External system connections with direction, purpose, and data exchange patterns
- **API Surface**: The customer-designed operations and queries that the application exposes or consumes, expressed as technology-stack-independent operation specifications
- **Data Exchange Patterns**: Import, export, synchronization, and real-time event patterns between the application and external systems
- **Authentication and Authorization Intent**: Access control patterns expressed as business-level role and permission specifications

### 3.6 Genome Representation Formats

The application genome supports dual-schema representation:

- **Flat Schema (Document/Tabular)**: The genome is representable as a structured document (YAML, JSON) or tabular format suitable for sequential reading, code generation, and document-oriented consumption. Each genome facet is expressed as a hierarchical structure of named components with typed properties.

- **Graph Schema (Entity-Relationship/Dependency)**: The genome is simultaneously representable as a directed graph where nodes represent genome components (entities, workflows, rules, screens, integrations) and edges represent relationships (references, triggers, dependencies, data flows). The graph schema enables dependency analysis, impact assessment, and structural comparison across genome versions.

Both representations are derived from a single canonical genome model and are guaranteed to be consistent with each other.

---

## 4. Summary of Invention

The present invention provides a system and method for modeling, extracting, and maintaining application genomes -- canonical representations of application intent, structure, and behavior -- from enterprise software systems. The system asserts and operationalizes the principle that **customers own the business logic they designed** -- the platform is merely the storage and execution vehicle.

The system accepts application artifacts from any enterprise software system -- including but not limited to configuration-driven platforms, low-code/no-code environments, SaaS applications, and custom-built enterprise systems -- through multiple ingestion modalities (configuration exports, API specifications, video demonstrations, business documents, and process diagrams) and produces a unified, portable application genome.

The extraction process operates exclusively at the business-intent level, excluding proprietary platform execution code, excluding platform runtime architecture, and excluding internal vendor APIs and system logic. The output genome represents only the customer's authored business intent in a platform-neutral, canonical form.

The pipeline employs a **hybrid processing architecture** that combines deterministic stages (rule-based parsing, schema validation, structural analysis) with non-deterministic stages (AI-driven semantic extraction, behavioral pattern recognition, intent inference) to maximize both reliability and depth of extraction.

The pipeline comprises specialized AI agents:

1. **Artifact Ingestion Agent** -- Accepts application artifacts from heterogeneous sources and modalities. For configuration exports: parses structured formats (XML, JSON, YAML, CSV), extracts records, counts components, and identifies the scope of customer-authored content. For API specifications: parses OpenAPI, GraphQL, or equivalent interface definitions to extract customer-designed operations. For video artifacts: analyzes screen recordings and demonstrations to extract UI semantics, workflow sequences, and interaction patterns. For document artifacts: parses business requirements documents, process diagrams, and operational procedures to extract process intent and business rules. Deterministic parsing stages handle format recognition and structural decomposition; non-deterministic AI stages handle semantic classification and intent inference.

2. **Genome Extraction Agent** -- Analyzes ingested artifacts using large language models with specialized prompting to extract customer-authored business logic independent of platform-specific implementation. Produces a raw genome encompassing all five facets: structural (entities, data models), behavioral (rules, patterns, events), process intent (workflows, approval chains), UI semantics (screens, forms, navigation), and system interactions (integrations, API surface). All extraction operates at the business-intent level; proprietary execution code, system-specific API signatures, and internal identifiers are excluded from the output.

3. **Genome Merger Agent** -- When artifacts from multiple sources, exports, or modalities are provided, deduplicates entities, merges definitions that span multiple artifacts, resolves naming conflicts by preferring more complete definitions, and normalizes naming conventions to produce a single unified genome. Handles cross-modal reconciliation (e.g., reconciling a workflow extracted from a configuration export with steps observed in a video demonstration).

4. **Deep Analysis Agent** -- Performs second-pass analysis to extract deeper behavioral patterns from the application's artifacts:
   - **Logic Patterns**: Reusable behavioral abstractions expressed in domain language
   - **Business Processes**: Step-by-step process flows with actors, actions, and system behaviors
   - **Events**: Trigger-effect mappings that capture event-driven business logic
   - **System Interaction Patterns**: Integration archetypes and data exchange patterns
   All patterns are expressed in platform-neutral, business-readable language, excluding proprietary execution code.

5. **Platform Transformer Agent** -- Converts the extracted genome into the canonical application genome format, with a platform abstraction layer that ensures all system-specific constructs have been replaced with generic, implementation-independent representations across all five genome facets. Produces both flat (document) and graph (entity-relationship) representations.

6. **Genome Validator Agent** -- Assesses the completeness and rebuildability of the extracted application genome:
   - **Completeness Score** (0-100): Quantifies extraction coverage across all genome facets
   - **Missing Components**: Identifies gaps where application intent may not have been captured
   - **Risks**: Flags areas where rebuilt applications may behave differently
   - **Recommendations**: Suggests additional artifacts or documentation to improve coverage
   - **Boundary Verification**: Confirms that no proprietary execution constructs, internal API references, or runtime architecture details remain in the output genome
   - **Cross-Modal Consistency**: Verifies that genome components extracted from different modalities are consistent with each other

---

## 5. Detailed Description

### 5.1 Philosophical Foundation: Customer IP Ownership

The system is built on the principle that when a customer designs a business process and implements it on an enterprise software system, the intellectual property of that design belongs to the customer. Specifically:

- The **customer** conceived the business requirement (e.g., "HR case submissions should be routed by region and require manager approval")
- The **customer** designed the workflow (submission -> routing -> approval -> fulfillment)
- The **customer** defined the data model (HR Case, Employee, Task, Agent Group)
- The **customer** specified the business rules (auto-route by region, escalate after SLA breach)
- The **customer** designed the user experience (submission forms, dashboard views, navigation paths)
- The **customer** defined the system interactions (integrations with external HR systems, notification channels)
- The **platform** merely provided the storage format and execution engine

The system extracts the customer's design intent -- not the platform's proprietary code, framework, or execution engine. System-specific terminology (function names, table prefixes, schema elements, widget identifiers) is systematically stripped and replaced with business-readable, platform-neutral equivalents. The output contains no proprietary execution code, no runtime architecture details, and no internal API references.

### 5.2 Legal Boundary Enforcement Mechanisms

The system enforces a strict legal boundary between customer-authored business intent and proprietary platform implementation through four coordinated mechanisms:

#### 5.2.1 System-Specific Identifier Removal

At each stage of the extraction pipeline, system-specific identifiers are identified and removed or replaced. This includes:

- **Internal namespace prefixes** (e.g., proprietary schema prefixes, system-generated namespace qualifiers) are stripped and replaced with customer-defined business names or semantically equivalent generic identifiers.
- **Platform object identifiers** (e.g., internal GUIDs, system-generated record keys, proprietary scope identifiers) are discarded entirely, as they are artifacts of the system's storage implementation and carry no customer-authored business meaning.
- **System-specific field names** (e.g., internal column names that encode execution semantics rather than business meaning) are mapped to descriptive, platform-neutral field names derived from the customer's labels or contextual analysis.
- **Proprietary schema elements and namespaces** specific to the system's export format are consumed during parsing but not propagated to the output genome.

#### 5.2.2 Platform-Neutral Representation Conversion

All extracted artifacts are converted into platform-neutral representations that express business intent without encoding any system-specific execution semantics:

- **Workflows** are represented as ordered sequences of business steps (actor, action, outcome) rather than system-specific execution graph definitions, state machine encodings, or proprietary orchestration formats.
- **Business rules** are expressed as declarative trigger-condition-action triples in natural language rather than as system-specific scripting language, proprietary function calls, or platform API invocations.
- **Data models** are expressed as entity-relationship structures with business-purpose annotations rather than system-specific table schemas, proprietary field types, or platform-internal relationship encodings.
- **UI specifications** are expressed as abstract screen-component hierarchies (form, field, button) with business-purpose annotations rather than system-specific widget definitions, proprietary rendering directives, or platform UI framework constructs.

#### 5.2.3 Runtime Reconstruction Prevention

The system is architecturally designed to prevent the output genome from being used to reconstruct any system's proprietary runtime, execution engine, or internal API surface:

- **No execution code is extracted**: The system summarizes business logic at the intent level rather than extracting or reproducing any executable code, scripts, or compiled artifacts from the platform.
- **No API signatures are preserved**: System-internal API endpoints, method signatures, parameter schemas, and authentication mechanisms are excluded from the output.
- **No runtime architecture is encoded**: The output genome contains no information about any system's execution engine, request processing pipeline, caching layers, database query patterns, or internal service architecture.
- **No platform schema is reproducible**: The output genome's data model represents the customer's business entities at a conceptual level; it cannot be used to reconstruct any system's internal database schema, indexing strategy, or storage implementation.

#### 5.2.4 Business-Intent Abstraction Layer

The system employs a multi-level abstraction approach to represent all extracted customer IP as business intent:

- **Level 1 -- Raw Extraction**: Customer-authored content is identified and separated from platform system records. System-specific formatting is removed.
- **Level 2 -- Semantic Normalization**: Extracted components are normalized into a canonical genome vocabulary that is system-independent. Business names replace internal identifiers.
- **Level 3 -- Behavioral Abstraction**: Business logic is abstracted into reusable patterns (approval flows, lifecycle management, event-driven rules) expressed in domain language, not platform language.
- **Level 4 -- Portable Architecture**: The genome is transformed into a technology-stack-independent architecture specification (domain model, services, API, UI, automation) that can be implemented on any platform without reference to the originating system.

At each abstraction level, the system moves further from the system's implementation details and closer to the customer's pure business intent. The final output at Level 4 bears no structural, syntactic, or semantic resemblance to any system's proprietary architecture.

### 5.3 System Architecture

```
Application Artifacts (multi-modal)
  * Configuration exports (XML, JSON, YAML, CSV)
  * API specifications (OpenAPI, GraphQL, WSDL)
  * Video demonstrations (screen recordings, walkthroughs)
  * Business documents (requirements, process diagrams, SOPs)
       |
[Artifact Ingestion Agent]
  * Deterministic: format detection, structural parsing, record counting
  * Non-deterministic (AI): content classification, intent detection
  * Identify customer-authored components
  * Exclude platform infrastructure records
       | parsed artifact data (customer content only, multi-modal)
[Genome Extraction Agent (LLM)]
  * Extract customer-authored business logic independent of platform implementation
  * Map system artifacts to canonical genome facets
  * Strip system-specific terminology, identifiers, and schema elements
  * Exclude proprietary execution code
       | raw application genome (platform-neutral, five facets)
[Genome Merger Agent (LLM)] -- for multi-source/multi-modal
  * Deduplicate across sources and modalities
  * Merge partial definitions
  * Normalize naming conventions
  * Reconcile cross-modal observations
       | unified application genome
[Deep Analysis Agent (LLM)]
  * Extract reusable behavioral patterns
  * Map business processes with actors and steps
  * Identify event-driven business logic and system interaction patterns
  * Express all patterns as business intent
       | enriched genome with patterns + processes
[Platform Transformer Agent (LLM)]
  * Convert to canonical genome format via abstraction layer
  * Generate flat schema (document) and graph schema (entity-relationship)
  * Produce rebuild-ready specification
  * Verify no system-specific constructs remain
       | canonical application genome (dual-schema, system-independent)
[Genome Validator Agent (LLM)]
  * Assess completeness (0-100 score per facet)
  * Identify missing components and risks
  * Generate recommendations
  * Verify legal boundary compliance
  * Check cross-modal consistency
       | validated genome with quality report + boundary audit
[Genome Repository Service]
  * Store versioned genome with full history
  * Maintain flat + graph representations
  * Taxonomized directory structure
  * Version-controlled with audit trail
  * Persistent system of record
```

### 5.4 Multi-Modal Artifact Ingestion

The Artifact Ingestion Agent accepts application artifacts from heterogeneous sources and modalities through a hybrid processing pipeline:

#### 5.4.1 Configuration Export Ingestion (Deterministic + Non-Deterministic)

**Deterministic stage**: Reads structured export files (XML, JSON, YAML, CSV), identifies root elements and record containers, counts records, and extracts structural metadata. Handles variations in schema across different systems and export formats.

**Non-deterministic stage**: Uses AI-driven analysis to classify records as customer-authored versus system-internal, identify business-relevant components within ambiguous structures, and infer component purposes from naming patterns and contextual relationships.

#### 5.4.2 API Specification Ingestion (Deterministic + Non-Deterministic)

**Deterministic stage**: Parses OpenAPI, GraphQL, WSDL, or equivalent interface specifications. Extracts endpoints, operations, parameter schemas, and response definitions.

**Non-deterministic stage**: Uses AI-driven analysis to distinguish customer-designed API operations from platform-infrastructure endpoints, infer business intent from operation names and descriptions, and extract data exchange patterns.

#### 5.4.3 Video Artifact Ingestion (Non-Deterministic)

**Non-deterministic stage**: Analyzes screen recordings and video demonstrations using multimodal AI to extract:
- **UI Semantics**: Screen layouts, form structures, navigation paths, and component behaviors observed during demonstrations
- **Workflow Sequences**: Step-by-step process flows as demonstrated by users in the recordings
- **Interaction Patterns**: User actions, system responses, and decision points captured in the demonstration
- **Business Context**: Explanatory narration or annotations that provide business rationale for observed behaviors

#### 5.4.4 Document Artifact Ingestion (Non-Deterministic)

**Non-deterministic stage**: Analyzes business requirements documents, process diagrams, standard operating procedures, and operational documentation using AI to extract:
- **Process Intent**: Business processes, approval chains, and escalation paths described in documentation
- **Business Rules**: Operational rules, policies, and decision criteria specified in documents
- **Data Requirements**: Entity definitions, field specifications, and relationship descriptions from requirements documents
- **Integration Requirements**: External system connections and data exchange needs described in documentation

### 5.5 Customer IP Extraction via LLM

The Genome Extraction Agent uses specialized prompting that instructs the LLM to extract customer-authored business logic independent of platform-specific implementation:

1. **Identify customer-authored components** within the ingested artifacts, distinguishing customer-designed business logic from system infrastructure, platform boilerplate, and vendor-internal constructs.

2. **Extract and normalize** into the canonical genome facets, excluding proprietary execution code, excluding runtime architecture, and excluding internal APIs and system logic:
   - **Structural Facet**: Domain entities, data schema, taxonomy
   - **Behavioral Facet**: Business rules, behavioral patterns, state machines, event mappings
   - **Process Intent Facet**: Workflows, process flows, approval chains, escalation paths
   - **UI Semantics Facet**: Screen specifications, form definitions, navigation structure, component semantics
   - **System Interaction Facet**: Integration points, API surface, data exchange patterns

3. **Strip system-specific terminology and proprietary constructs**: Convert function names, table prefixes, internal identifiers, schema references, widget types, and API method names to business-readable, platform-neutral equivalents.

### 5.6 Multi-Source Merging and Cross-Modal Reconciliation

When artifacts from multiple sources or modalities are provided, the Genome Merger Agent:

1. **Deduplicates**: Identifies the same entity, workflow, or rule appearing in multiple artifacts by semantic matching
2. **Merges partial definitions**: Combines genome components that are partially defined across multiple artifacts
3. **Resolves conflicts**: When the same component appears with different definitions, prefers the more complete version or merges complementary attributes
4. **Normalizes naming**: Ensures consistent naming conventions across the unified genome
5. **Reconciles cross-modal observations**: Aligns genome components extracted from different modalities (e.g., a workflow extracted from configuration export with steps observed in a video demonstration, supplemented by business rules described in documentation)

The merger uses LLM analysis to understand semantic equivalence beyond exact string matching and to reconcile observations from fundamentally different artifact modalities.

### 5.7 Behavioral Pattern Extraction

The Deep Analysis Agent performs a second-pass extraction focused on reusable behavioral patterns:

**Logic Patterns** -- Abstracted from system-specific implementations:
```yaml
- name: decrement_inventory_on_checkout
  trigger: checkout_created
  action: reduce inventory count
  reusable_pattern: inventory_decrement
```

Instead of system-specific function references, the system extracts the customer's business intent as a named, reusable pattern. System-specific function signatures are discarded; only the customer-authored business meaning is retained.

**Business Processes** -- Step-by-step with actors:
```yaml
- name: access_provisioning
  steps:
    - step: submit_request
      actor: employee
      action: submits access request
      system_behavior: create case record
    - step: manager_approval
      actor: manager
      action: reviews and approves
      system_behavior: update status, notify fulfillment
```

**Events** -- Trigger-effect mappings:
```yaml
- name: sla_breach_escalation
  trigger: case response time exceeds SLA threshold
  downstream_effects:
    - escalate to supervisor
    - send notification to management
    - update priority to critical
```

**System Interaction Patterns** -- Integration archetypes:
```yaml
- name: hr_system_sync
  pattern: bidirectional_sync
  external_system: HR system of record
  data_exchanged: [employee_records, org_hierarchy]
  trigger: scheduled + event-driven
  business_purpose: "Keep employee data consistent across systems"
```

All behavioral patterns express the customer's business intent in domain language. No system-specific execution semantics, proprietary event system internals, or internal API references are included.

### 5.8 Platform-Neutral Transformation and Dual-Schema Output

The Platform Transformer Agent converts the application genome into the canonical format through a platform abstraction layer that replaces all remaining system-specific constructs with generic, implementation-independent representations.

**Flat Schema (Document) Representation:**

```yaml
application_genome:
  metadata:
    genome_version: "2.0"
    extraction_date: "2026-03-15"
    source_system_type: "enterprise_software_system"
    artifact_modalities: [configuration_export, api_spec, video, document]

  structural:
    domain_model:
      entities:
        - name: hr_case
          fields: [id, employee_id, type, status, priority, description]
          purpose: "Tracks employee HR requests"
          relationships:
            - target: employee
              type: belongs_to
            - target: task
              type: has_many

  behavioral:
    business_rules:
      - name: auto_route_by_region
        trigger: case_created
        condition: employee.region is defined
        action: assign to regional HR team based on employee location
    patterns:
      - name: sla_escalation
        archetype: escalation_chain
        trigger: threshold_breach
        behavior: progressive_escalation

  process_intent:
    workflows:
      - name: case_lifecycle
        steps: [submit, route, approve, fulfill, resolve, close]
        actors: [employee, manager, hr_agent]

  ui_semantics:
    screens:
      - name: case_submission_form
        purpose: "Allow employees to submit HR cases"
        components: [employee_lookup, case_type_dropdown, description_field, submit_button]

  system_interactions:
    integrations:
      - name: hr_system_sync
        direction: bidirectional
        purpose: "Employee data synchronization"
    api_surface:
      - operation: submit_case
        method: POST
        purpose: "Submit new HR case"
      - operation: approve_case
        method: POST
        purpose: "Approve pending case"
```

**Graph Schema (Entity-Relationship) Representation:**

```yaml
genome_graph:
  nodes:
    - id: entity:hr_case
      type: entity
      facet: structural
      properties: {name: hr_case, purpose: "Tracks employee HR requests"}
    - id: workflow:case_lifecycle
      type: workflow
      facet: process_intent
      properties: {name: case_lifecycle, steps: 6}
    - id: rule:auto_route_by_region
      type: business_rule
      facet: behavioral
      properties: {name: auto_route_by_region, trigger: case_created}
    - id: screen:case_submission_form
      type: screen
      facet: ui_semantics
      properties: {name: case_submission_form, components: 4}

  edges:
    - from: workflow:case_lifecycle
      to: entity:hr_case
      relationship: operates_on
    - from: rule:auto_route_by_region
      to: entity:hr_case
      relationship: triggered_by
    - from: screen:case_submission_form
      to: entity:hr_case
      relationship: creates
    - from: workflow:case_lifecycle
      to: screen:case_submission_form
      relationship: initiated_by
```

This output is explicitly designed to be **rebuildable** on any technology stack without reference to the originating system. The genome contains no system-specific identifiers, no proprietary schema elements, no execution constructs, and no internal API references. It represents exclusively the customer's authored business intent in a canonical, dual-schema form.

### 5.9 Completeness and Rebuildability Assessment

The Genome Validator Agent produces a quality report:

```yaml
validation:
  completeness_score: 78
  facet_scores:
    structural: 92
    behavioral: 81
    process_intent: 74
    ui_semantics: 68
    system_interactions: 55

  missing_components:
    - type: integration_credentials
      facet: system_interactions
      description: "Integration connection details not available in provided artifacts"
    - type: complex_business_logic
      facet: behavioral
      description: "Complex scripted logic may not be fully captured in business rule summaries"

  risks:
    - description: "Approval delegation logic may behave differently on target platform"
      impact: "Medium - manual testing recommended"

  recommendations:
    - action: "Provide additional artifacts covering integration definitions"
    - action: "Provide video demonstration of approval delegation workflow"
    - action: "Review extracted business rules against original system for completeness"

  cross_modal_consistency:
    status: "PASS"
    notes: "Workflow steps from configuration export consistent with video demonstration"

  boundary_audit:
    platform_identifiers_removed: true
    vendor_api_references_removed: true
    proprietary_schema_elements_removed: true
    execution_code_excluded: true
    audit_status: "PASS - no proprietary constructs detected in output genome"
```

The completeness score enables automated decision-making: scores above 80 indicate the genome is likely sufficient for rebuilding; scores below 50 suggest additional source material is needed. Per-facet scores identify which aspects of the application are well-captured and which need additional artifact input. The boundary audit confirms that the output genome contains no proprietary constructs.

### 5.10 Genome as a Persistent System of Record

The application genome is designed to serve as a **persistent, versioned, reusable system of record** for the application's business intent throughout its lifecycle:

#### 5.10.1 Persistence and Versioning

The genome is stored in a version-controlled repository with full change history. Each extraction, enrichment, or manual refinement creates a new genome version with:
- **Immutable version snapshots**: Each genome version is preserved as a complete, self-contained artifact that can be retrieved, compared, or restored at any point
- **Change attribution**: Each genome modification records what changed, when, why, and from which source artifact or user action
- **Diff capability**: Any two genome versions can be compared to produce a structured diff showing added, modified, and removed genome components across all facets
- **Branch support**: Multiple genome variants (e.g., representing different migration scenarios or platform-specific adaptations) can coexist as branches with merge capability

#### 5.10.2 Lifecycle Independence

The genome persists independently of any deployment platform or technology stack:
- **Pre-migration**: The genome serves as the authoritative specification of what the application does, extracted from the current platform
- **During migration**: The genome serves as the source of truth for what must be rebuilt on the target platform, with completeness scores tracking migration progress
- **Post-migration**: The genome serves as living documentation of the application's business intent, updated as the application evolves on the new platform
- **Cross-platform**: The genome can be used to deploy the same application intent on multiple platforms simultaneously, or to compare implementations across platforms against the canonical genome

#### 5.10.3 Reusability

The genome's canonical representation enables reuse across multiple contexts:
- **Code generation**: The genome can be consumed by code generation tools to produce application scaffolding, API implementations, database schemas, and UI components on any target technology stack
- **Compliance and audit**: The genome provides a business-readable specification of what the application does, suitable for regulatory review, compliance auditing, and risk assessment without requiring access to platform-specific implementation details
- **Application portfolio analysis**: Multiple application genomes can be compared, analyzed for redundancy, and consolidated at the business-intent level
- **Knowledge transfer**: The genome serves as platform-independent documentation that enables teams to understand application behavior without expertise in any specific platform
- **Transformation recipes**: Reusable transformation patterns (translation recipes) can be applied to the genome to produce target-platform-specific implementations, and these recipes themselves become versioned, reusable assets

#### 5.10.4 Genome Evolution

The genome evolves through multiple mechanisms:
- **Re-extraction**: New artifacts from the source system can be ingested to update the genome with changes made on the originating platform
- **Manual enrichment**: Domain experts can add, refine, or correct genome components based on knowledge not captured in source artifacts
- **Cross-pollination**: Behavioral patterns, process templates, and architectural patterns extracted from one application genome can be applied to other applications
- **Translation application**: Transformation recipes applied to the genome produce new genome facets (e.g., target-platform-specific implementations) that are stored as genome extensions

### 5.11 Hybrid Pipeline Architecture

The extraction pipeline employs a coordinated hybrid architecture that combines deterministic and non-deterministic processing stages:

#### 5.11.1 Deterministic Stages

Deterministic stages provide reliable, repeatable processing for well-structured inputs:
- **Format detection and parsing**: File type identification, XML/JSON/YAML/CSV parsing, schema validation
- **Record counting and metadata extraction**: Structural analysis of export files
- **Schema mapping**: Mapping known export schemas to canonical genome structures using predefined rules
- **Deduplication by identity**: Matching identical records across multiple exports by primary key or canonical identifier
- **Validation**: Schema validation of genome output, completeness scoring arithmetic, boundary audit checks

#### 5.11.2 Non-Deterministic Stages

Non-deterministic stages provide AI-driven semantic analysis for ambiguous, unstructured, or cross-modal inputs:
- **Content classification**: Distinguishing customer-authored components from system infrastructure using contextual analysis
- **Semantic extraction**: Interpreting business intent from configuration patterns, script summaries, and naming conventions
- **Behavioral pattern recognition**: Identifying reusable business patterns across heterogeneous artifacts
- **Cross-modal reconciliation**: Aligning observations from different artifact modalities (configuration, video, document)
- **Intent inference**: Inferring the business purpose of components when explicit documentation is absent
- **Natural language summarization**: Producing business-readable descriptions of complex logic patterns

#### 5.11.3 Coordination

The hybrid pipeline coordinates deterministic and non-deterministic stages through:
- **Deterministic-first processing**: Where possible, deterministic stages run first to provide structured context that improves non-deterministic stage accuracy
- **Confidence scoring**: Non-deterministic stages produce confidence scores that determine whether human review is recommended
- **Fallback chains**: When non-deterministic stages produce low-confidence results, alternative extraction strategies are attempted
- **Consistency verification**: Deterministic validation stages verify that non-deterministic outputs are structurally valid and internally consistent

### 5.12 Non-Derivative Transformation Guarantee

The system's output -- the portable application genome -- is not a derivative work of the originating enterprise software system for the following reasons:

**1. No Protected Expression Is Reproduced.** The system does not copy, reproduce, or adapt any protectable expression of the platform vendor. Platform source code, compiled binaries, proprietary frameworks, and vendor-authored UI components are never accessed, read, or extracted. The system operates exclusively on customer-provided application artifacts, which themselves are records of the customer's design decisions stored in the system's format.

**2. The Transformation Operates at the Idea Level, Not the Expression Level.** Copyright protects expression, not ideas. The customer's business intent -- "route HR cases by region," "require manager approval before fulfillment," "escalate when SLA is breached" -- constitutes unprotectable ideas, processes, and methods of operation. The system extracts these ideas and re-expresses them in an entirely new canonical form that shares no protectable expression with any platform.

**3. Systematic Elimination of System-Specific Expression.** The legal boundary enforcement mechanisms (Section 5.2) ensure that all system-specific identifiers, schema elements, API signatures, scripting constructs, and execution semantics are systematically removed during extraction. What remains is the customer's business intent expressed in a new, independently structured canonical format.

**4. No Substantial Similarity to Platform Implementation.** The output genome bears no structural, syntactic, or organizational resemblance to any platform's proprietary implementation. The four-level abstraction process (Section 5.2.4) ensures progressive divergence from the source format at each stage.

**5. Independent Utility Without Platform Reference.** The portable genome is designed to be consumed by development teams and code generation tools that have no access to and no knowledge of the originating platform. The genome is self-contained and can be implemented on any technology stack without referencing any platform's documentation, APIs, or architecture.

---

## 6. Key Claims

### Independent Claims

**Claim 1.** A computer-implemented method for extracting customer-authored business logic independent of platform-specific implementation from an enterprise software system and producing an application genome comprising:
(a) receiving one or more application artifacts containing customer-authored business logic embedded in system-specific format, wherein the artifacts originate from one or more enterprise software systems including configuration-driven platforms, low-code platforms, SaaS applications, or custom-built enterprise systems;
(b) parsing the application artifacts to identify and separate customer-authored components from system infrastructure artifacts, excluding proprietary execution code, runtime architecture, and internal system APIs;
(c) extracting customer-authored business logic independent of platform-specific implementation using one or more language models, wherein the extraction produces a canonical representation encompassing structural components, behavioral patterns, process intent, UI semantics, and system interactions;
(d) converting system-specific terminology, identifiers, and proprietary schema elements into platform-neutral, business-readable equivalents, thereby removing all system-specific execution constructs;
(e) producing an application genome -- a canonical representation of application intent, structure, and behavior -- that represents the customer's intellectual property independently of the originating system, wherein the genome contains no proprietary execution code, no runtime architecture details, and no internal API references;
(f) assessing the completeness of the extracted application genome through automated validation with a quantified completeness score and a boundary audit confirming the absence of proprietary constructs in the output.

**Claim 2.** A system for producing application genomes from enterprise software system artifacts comprising:
(a) an artifact ingestion agent configured to accept application artifacts from heterogeneous sources and modalities, and to identify customer-authored components, excluding system infrastructure records and internal metadata;
(b) a genome extraction agent configured to extract customer-authored business logic independent of platform-specific implementation using one or more language models with specialized prompting, producing a genome encompassing structural, behavioral, process intent, UI semantic, and system interaction facets;
(c) a genome merger configured to deduplicate and unify customer IP across multiple artifacts and modalities;
(d) a deep analysis agent configured to extract reusable behavioral patterns from customer artifacts, abstracting system-specific implementations into business-readable logic patterns;
(e) a platform transformer configured to convert the extracted genome into a canonical, platform-neutral representation through a platform abstraction layer that replaces all system-specific constructs with generic, implementation-independent representations;
(f) a genome validator configured to assess extraction completeness, identify gaps, and verify that no proprietary constructs remain in the output genome.

**Claim 3.** A method for producing a platform-neutral portable application architecture from enterprise software system artifacts comprising:
(a) extracting customer-authored business logic independent of platform-specific implementation from application artifacts, excluding proprietary execution code, runtime architecture, and internal system APIs;
(b) transforming extracted entities into domain model objects expressed as platform-independent data structures;
(c) transforming extracted business rules into automation rules expressed as declarative trigger-action pairs in business-readable language;
(d) transforming extracted UI components into screen specifications expressed as abstract screen-component hierarchies with business-purpose annotations;
(e) transforming extracted operations into API specifications expressed as technology-stack-independent operation definitions;
(f) transforming extracted workflows into service orchestration specifications expressed as ordered business step sequences;
(g) transforming extracted integration points into system interaction specifications expressed as platform-neutral data exchange patterns;
(h) producing a unified portable genome document suitable for rebuilding the application on a different technology stack, wherein the document contains exclusively customer-authored business intent and no proprietary constructs.

**Claim 4.** A computer-implemented method for converting application artifacts from any enterprise software system into a canonical intermediate representation for cross-platform portability comprising:
(a) receiving application artifacts from one or more enterprise software systems, wherein the artifacts encode customer-authored application logic in one or more system-specific formats;
(b) analyzing the application artifacts to identify components that represent customer-authored business intent as distinct from system infrastructure, platform framework code, and vendor-internal constructs;
(c) extracting the identified customer-authored components and transforming them into a canonical intermediate representation -- an application genome -- that is independent of any specific enterprise software system, technology stack, or implementation framework;
(d) wherein the canonical intermediate representation encompasses at minimum: a structural facet representing the application's data model and entity relationships, a behavioral facet representing the application's business rules and operational logic, and a process facet representing the application's workflows and orchestration sequences;
(e) wherein the canonical intermediate representation is consumable by downstream systems to produce implementations on target technology stacks without reference to the originating system;
(f) wherein the transformation systematically removes all system-specific identifiers, proprietary schema elements, and execution constructs such that the canonical intermediate representation cannot be used to reconstruct the originating system's proprietary architecture.

### Dependent Claims

**Claim 5.** The method of Claim 1 wherein the customer-authored components are identified by distinguishing customer configuration records from system infrastructure records within the application artifacts.

**Claim 6.** The method of Claim 1 wherein converting system-specific terminology comprises replacing internal function names, table prefixes, system identifiers, and proprietary schema references with business-readable names derived from the customer's labels and descriptions.

**Claim 7.** The system of Claim 2 wherein the genome merger resolves conflicts between duplicate component definitions appearing in multiple artifacts by preferring the more complete definition.

**Claim 8.** The system of Claim 2 wherein the deep analysis agent extracts three categories of behavioral patterns: logic patterns (trigger-action abstractions), business processes (step-by-step with actors), and events (trigger-effect mappings), all expressed as customer business intent independent of system-specific execution semantics.

**Claim 9.** The method of Claim 1 further comprising extracting reusable behavioral patterns including: inventory management patterns, approval flow patterns, request lifecycle patterns, status transition patterns, escalation chain patterns, and data mutation patterns, wherein each pattern represents the customer's authored business logic independent of platform-specific implementation.

**Claim 10.** The method of Claim 3 wherein the portable architecture specification comprises: domain model entities, application services with typed inputs/outputs, ordered workflow steps, API operation definitions, UI screen specifications with components, automation rules as trigger-action pairs, and system interaction specifications, and wherein the specification excludes all proprietary execution code, runtime architecture, and internal system APIs.

**Claim 11.** The method of Claim 1 wherein the completeness score is computed on a 0-100 scale based on the presence and richness of extracted components across each genome facet: structural, behavioral, process intent, UI semantics, and system interactions.

**Claim 12.** The system of Claim 2 further comprising a genome repository service that stores the extracted genome as a persistent, versioned system of record with full change history, diff capability, and branch support.

**Claim 13.** The method of Claim 1 wherein the agents execute with real-time progress streaming via Server-Sent Events, each agent reporting start, completion with metrics, or error status.

**Claim 14.** The method of Claim 1 wherein the genome merger uses one or more language models to identify semantic equivalence between components beyond exact name matching.

**Claim 15.** The method of Claim 3 wherein the portable architecture specification is structured as YAML or JSON and can be consumed by code generation tools to produce application scaffolding on target technology stacks.

**Claim 16.** The method of Claim 1 further comprising a validation report that identifies: missing components (with facet, type, and description), risks (with impact assessment), recommendations (actionable steps to improve coverage), cross-modal consistency status, and a boundary audit confirming the absence of proprietary constructs.

**Claim 17.** The system of Claim 2 wherein the artifact ingestion agent supports multiple artifact formats and handles variations in schema across different enterprise software systems and export tools.

**Claim 18.** The method of Claim 1 wherein the extraction is performed without accessing the originating system's runtime environment, operating solely on exported or documented application artifacts provided by the customer.

**Claim 19.** The system of Claim 2 wherein the genome extraction agent uses a system prompt that explicitly instructs the model to summarize business intent rather than reproducing proprietary code, and to exclude proprietary execution code, runtime architecture, and internal APIs from all output.

**Claim 20.** The method of Claim 1 further comprising support for multi-source ingestion wherein artifacts from multiple systems, exports, or modalities are combined into a single unified genome, enabling recovery of customer IP that spans multiple systems, scopes, or artifact types.

**Claim 21.** A non-transitory computer-readable medium storing instructions that, when executed by a processor, cause the processor to perform the method of Claim 1.

**Claim 22.** The method of Claim 1 further comprising a platform abstraction layer that converts all system-specific constructs into generic, implementation-independent representations at four progressive levels of abstraction: raw extraction, semantic normalization, behavioral abstraction, and portable architecture, wherein each successive level increases the distance from the originating system's implementation and moves closer to the customer's pure business intent.

**Claim 23.** The method of Claim 1 further comprising a system-specific artifact stripping process that systematically identifies and removes system-specific identifiers including internal namespace prefixes, platform object identifiers, system-specific field names, and proprietary schema elements, replacing them with customer-defined business names or semantically equivalent generic identifiers, such that the output genome contains no artifacts traceable to the originating system's proprietary implementation.

**Claim 24.** The method of Claim 1 wherein the extraction produces an intent-level reconstruction of the customer's business logic rather than an implementation-level reproduction of the system's execution artifacts, such that the output genome expresses what the customer's application does in business terms without encoding how the originating system implements it, and wherein the output genome bears no structural, syntactic, or organizational resemblance to the originating system's implementation.

**Claim 25.** The method of Claim 1 further comprising multi-modal extraction wherein the application artifacts include two or more of: configuration exports in structured data formats, API specifications, video demonstrations or screen recordings, and business documents or process diagrams, and wherein the genome extraction pipeline ingests, analyzes, and reconciles observations from the multiple modalities into a unified application genome.

**Claim 26.** The method of Claim 1 wherein the application genome is represented simultaneously in both a flat schema suitable for document-oriented consumption and code generation, and a graph schema suitable for dependency analysis and structural comparison, wherein both representations are derived from a single canonical genome model and are guaranteed to be mutually consistent.

**Claim 27.** The method of Claim 1 wherein the extraction pipeline comprises both deterministic processing stages that perform rule-based parsing, schema validation, and structural analysis, and non-deterministic processing stages that perform AI-driven semantic extraction, behavioral pattern recognition, and intent inference, coordinated through a hybrid pipeline architecture that sequences deterministic stages before non-deterministic stages where possible and employs confidence scoring to determine when human review is recommended.

**Claim 28.** The method of Claim 4 wherein the canonical intermediate representation further encompasses a UI semantics facet representing the application's user interface intent and a system interaction facet representing the application's integration patterns and external communication specifications.

**Claim 29.** The method of Claim 4 wherein the canonical intermediate representation is maintained as a persistent, versioned system of record with immutable version snapshots, change attribution, diff capability across versions, and branch support for representing multiple migration or adaptation scenarios.

**Claim 30.** The system of Claim 2 further comprising a genome evolution mechanism wherein the application genome is updated through re-extraction from updated source artifacts, manual enrichment by domain experts, cross-pollination of patterns from other application genomes, and application of reusable transformation recipes.

---

## 7. Advantages Over Prior Art

1. **Category-defining genome model**: Establishes the application genome as a canonical representation of application intent, structure, and behavior -- a new category of software artifact distinct from source code, configuration, and documentation
2. **Customer IP sovereignty**: Explicitly separates customer-authored business logic from platform implementation, asserting customer ownership of their designs
3. **Vendor lock-in remediation**: Produces portable genomes that free customer IP from dependence on any single vendor or technology stack
4. **Platform-neutral output**: Canonical genome specification can be rebuilt on any modern technology stack without reference to the originating system
5. **Multi-modal extraction**: Accepts application artifacts from heterogeneous sources (configuration exports, APIs, video, documents) enabling genome extraction even when no single artifact type captures the complete application
6. **Multi-source unification**: Handles the real-world case where customer IP is distributed across multiple systems, exports, or artifact types
7. **Behavioral abstraction**: Extracts reusable patterns (approval flows, inventory management, request lifecycles) in business-readable language, independent of system-specific function names
8. **Dual-schema representation**: Provides both flat (document) and graph (entity-relationship) representations of the same genome, enabling different consumption patterns for code generation, dependency analysis, and portfolio management
9. **Hybrid pipeline**: Combines deterministic reliability with AI-driven depth, using rule-based stages for structured inputs and AI stages for semantic analysis, coordinated through confidence scoring
10. **Quality quantification**: Per-facet completeness scoring and gap analysis enable informed decision-making about extraction sufficiency
11. **No runtime access required**: Operates solely on exported or documented application artifacts -- no access to any system's live environment is needed
12. **Legal defensibility**: Systematic removal of all system-specific constructs and four-level abstraction process ensures the output is demonstrably not a derivative work of the originating platform
13. **Persistent system of record**: The genome serves as a versioned, reusable asset throughout the application's lifecycle -- not a one-time migration artifact but a living representation of business intent
14. **Scalability**: Automated pipeline enables extraction from large application portfolios that would be infeasible to recover manually
15. **Audit trail**: Version-controlled storage with change attribution provides complete provenance of extracted customer IP
16. **Legal boundary enforcement**: Four-layer mechanism provides auditable proof that no proprietary constructs are present in the output
17. **Cross-platform applicability**: System is not specific to any particular enterprise software vendor or platform type -- applicable to configuration-driven platforms, low-code environments, SaaS applications, and custom-built systems

---

## 8. Drawings/Figures Description

**Figure 1: Application Genome Model** -- Conceptual diagram showing the five genome facets (structural, behavioral, process intent, UI semantics, system interactions) as a unified canonical model with relationships between facets.

**Figure 2: Customer IP vs. Platform IP** -- Conceptual diagram showing the boundary between customer-authored business intent and platform-provided infrastructure, with the extraction boundary clearly marked and explicit exclusion zones for proprietary execution code, runtime architecture, and internal APIs.

**Figure 3: Multi-Agent Pipeline Architecture** -- Block diagram showing the six agents (Artifact Ingestion, Genome Extraction, Genome Merger, Deep Analysis, Platform Transformer, Genome Validator) with data flow arrows, deterministic/non-deterministic stage indicators, and legal boundary enforcement checkpoints.

**Figure 4: Multi-Modal Ingestion Flow** -- Diagram showing how four artifact types (configuration export, API specification, video demonstration, business document) are ingested through modality-specific processing pipelines and converge into a unified extraction input.

**Figure 5: Multi-Source Merge and Cross-Modal Reconciliation Flow** -- Diagram showing how artifacts from multiple sources and modalities are parsed, individually extracted, and then merged into a unified genome with deduplication and cross-modal consistency verification.

**Figure 6: Behavioral Pattern Extraction** -- Example showing a system-specific script reference being transformed into a business-readable logic pattern, process, and event definition, with system-specific constructs being stripped at each transformation stage.

**Figure 7: Platform-Neutral Transformation** -- Side-by-side comparison showing system-specific artifacts (left) and the canonical genome (right) with mapping arrows between corresponding components.

**Figure 8: Dual-Schema Representation** -- Side-by-side view of the same genome in flat (document/YAML) and graph (entity-relationship/dependency) formats with correspondence annotations.

**Figure 9: Completeness Scoring Model** -- Radar chart showing per-facet completeness scores (structural, behavioral, process intent, UI semantics, system interactions) with example scores for a typical extraction.

**Figure 10: Genome as System of Record Lifecycle** -- Timeline diagram showing the genome's evolution from initial extraction through migration, post-migration updates, and ongoing maintenance as a persistent system of record.

**Figure 11: Hybrid Pipeline Architecture** -- Diagram showing the coordination of deterministic (rule-based) and non-deterministic (AI-driven) processing stages with confidence scoring and fallback chains.

**Figure 12: Portable Genome Structure** -- Entity-relationship diagram showing domain model, application services, API surface, UI model, automation rules, and system interactions with their relationships.

**Figure 13: Repository Output Structure** -- Directory tree showing versioned genome files, flat and graph representations, validation reports, and audit trail.

**Figure 14: Legal Boundary Enforcement Architecture** -- Four-layer diagram showing progressive abstraction from system-specific artifacts to platform-neutral business intent, with artifact stripping at each layer and boundary audit verification.

**Figure 15: Non-Derivative Transformation Flow** -- Structural comparison demonstrating progressive divergence from source format at each abstraction level.

**Figure 16: Cross-Platform Genome Applicability** -- Diagram showing the same genome extraction process applied to multiple enterprise software system types (configuration-driven, low-code, SaaS, custom-built) producing a unified canonical genome.

---

## 9. Inventors

[To be completed by filing attorney]

## 10. Filing Notes

- **Category-defining framing is critical**: This patent should be positioned as defining the category of "Application Genome Modeling" -- the first system to define, extract, and maintain a canonical representation of application intent, structure, and behavior. The five-facet genome model (structural, behavioral, process intent, UI semantics, system interactions) is the category definition.
- **Broad applicability**: The claims are deliberately not limited to any specific enterprise software vendor, platform type, or artifact format. Claim 4 in particular covers ANY system that converts application artifacts into a canonical intermediate representation for portability. This breadth should be preserved during prosecution.
- **IP ownership framing**: The core legal argument that customers own the business logic they design should be emphasized throughout prosecution.
- **No reverse engineering of platform code**: The system explicitly does NOT extract or reproduce proprietary execution code, runtime architecture, or internal APIs. It extracts only customer-authored business logic independent of platform-specific implementation. This distinction is essential for avoiding vendor IP claims.
- **Non-derivative work argument**: The four-level abstraction process (Section 5.2.4) and the Non-Derivative Transformation Guarantee (Section 5.12) provide a structured legal argument that the output genome is not a derivative work.
- **Multi-modal extraction as differentiation**: The ability to extract application genomes from heterogeneous artifact types (configuration, API, video, document) is a significant differentiator from any prior art focused solely on configuration migration.
- **Dual-schema representation as differentiation**: The simultaneous flat and graph representations of the same genome model, with guaranteed consistency, is independently novel.
- **Hybrid pipeline as differentiation**: The coordinated deterministic + non-deterministic pipeline architecture with confidence scoring is independently novel.
- **Genome as system of record**: The persistent, versioned, reusable genome concept is independently novel and distinguishes this from one-time migration tools.
- **Data portability regulations**: Reference relevant data portability rights (GDPR Article 20, proposed US data portability legislation) as additional support for the right to extract customer-authored configurations.
- **Configuration artifacts vs. source code**: Emphasize that application artifacts are customer data (business process definitions), not platform source code. The customer created the configurations; the platform stores them.
- **Claims 25-30 future-proof against competitors**: These dependent claims cover multi-modal extraction (Claim 25), dual-schema representation (Claim 26), and hybrid pipelines (Claim 27) -- anticipated competitive approaches.
- Consider filing as a continuation of Patent 1 to establish a patent family, or as an independent application given the expanded scope.
- Prior art search should focus on: data portability tools, application migration utilities, model-driven engineering, configuration management databases, vendor lock-in remediation systems, application portfolio management tools, digital twin platforms.

---

*This document is a technical disclosure for patent filing purposes. It should be reviewed by a registered patent attorney before formal claims are drafted and filed.*
